TY - JOUR
T1 - Quantitative analyses of the metaphase-to-anaphase transition reveal differential kinetic regulation for securin and cyclin B1
AU - Konishi, Makoto
AU - Shindo, Norihisa
AU - Komiya, Masataka
AU - Tanaka, Kozo
AU - Itoh, Takehiko
AU - Hirota, Toru
N1 - Funding Information:
We are grateful to Drs. Shinichiro Kanno and Akira Yasui (Tohoku University, Sendai) for mass spectrometry analysis; to Masatoshi Takagi (Riken, Wako) for phospho-Ki67 antibodies; Nobumoto Watanabe (Riken, Wako) for Pin1 constructs; to Norio Tanaka and Kazuhiko Uchida (JFCR, Tokyo) for intellectual inputs. Research in the laboratory of T.H. is supported by grants from the Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports and Technology of Japan (MEXT).
Funding Information:
We are grateful to Drs. Shinichiro Kanno and Akira Yasui (Tohoku University, Sendai) for mass spec-trometry analysis; to Masatoshi Takagi (Riken, Wako) for phospho-Ki67 antibodies; Nobumoto Watanabe (Riken, Wako) for Pin1 constructs; to Norio Tanaka and Kazuhiko Uchida (JFCR, Tokyo) for intellectual inputs. Research in the laboratory of T.H. is supported by grants from the Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports and Technology of Japan (MEXT).
Publisher Copyright:
© 2018, Biomedical Research Foundation. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Separation of sister chromatids is a drastic and irreversible step in the cell cycle. The key biochemistry behind this event is the proteolysis mediated by the ubiquitin ligase called the anaphase promoting complex, or APC/C. Securin and cyclin B1 are the two established substrates for APC/ C whose degradation releases separase and inactivates cyclin B1-dependent kinase 1 (cdk1), respectively, at the metaphase-to-anaphase transition. In this study, we have combined biochemical quantifications with mathematical simulations to characterize the kinetic regulation of securin and cyclin B1, in the cytoplasmic and chromosomal compartments, and found that they are differentially distributed and degraded with different rates. Modeling their interaction with separase predicted that activation timing of separase well coincides with the decline of securin-separase concentration in the cytoplasm. Notably, it also coincides with the peak of cyclin B1-separase level on chromosomes, which appeared crucial to coordinate the timing for separase activation and cdk1 inhibition. We have also conducted phosphoproteomic analysis and identified Ki67 as a chromosomal cdk1 substrate whose dephosphorylation is facilitated by cyclin B1-separase interaction in anaphase.
AB - Separation of sister chromatids is a drastic and irreversible step in the cell cycle. The key biochemistry behind this event is the proteolysis mediated by the ubiquitin ligase called the anaphase promoting complex, or APC/C. Securin and cyclin B1 are the two established substrates for APC/ C whose degradation releases separase and inactivates cyclin B1-dependent kinase 1 (cdk1), respectively, at the metaphase-to-anaphase transition. In this study, we have combined biochemical quantifications with mathematical simulations to characterize the kinetic regulation of securin and cyclin B1, in the cytoplasmic and chromosomal compartments, and found that they are differentially distributed and degraded with different rates. Modeling their interaction with separase predicted that activation timing of separase well coincides with the decline of securin-separase concentration in the cytoplasm. Notably, it also coincides with the peak of cyclin B1-separase level on chromosomes, which appeared crucial to coordinate the timing for separase activation and cdk1 inhibition. We have also conducted phosphoproteomic analysis and identified Ki67 as a chromosomal cdk1 substrate whose dephosphorylation is facilitated by cyclin B1-separase interaction in anaphase.
UR - http://www.scopus.com/inward/record.url?scp=85045550318&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045550318&partnerID=8YFLogxK
U2 - 10.2220/biomedres.39.75
DO - 10.2220/biomedres.39.75
M3 - Article
C2 - 29669986
AN - SCOPUS:85045550318
SN - 0388-6107
VL - 39
SP - 75
EP - 85
JO - Biomedical Research (Japan)
JF - Biomedical Research (Japan)
IS - 2
ER -